Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial

• Published in: Cardiovascular diabetology Vol. 18; no. 1; pp. 127 - 13
• Main Authors: Pedersen, Lene Rørholm, Olsen, Rasmus Huan, Anholm, Christian, Astrup, Arne, Eugen-Olsen, Jesper, Fenger, Mogens, Simonsen, Lene, Walzem, Rosemary L., Haugaard, Steen Bendix, Prescott, Eva
• Format: Journal Article
• Language: English
• Published: England BioMed Central 01.10.2019; BMC
• Subjects: Adiposity; Aerobic interval training; Aged; Biomarkers - blood; C-Reactive Protein - metabolism; Caloric Restriction; Coronary artery disease; Coronary Artery Disease - blood; Coronary Artery Disease - diagnosis; Coronary Artery Disease - physiopathology; Coronary Artery Disease - therapy; Denmark; Dyslipidaemia; Dyslipidemias - blood; Dyslipidemias - diagnosis; Dyslipidemias - physiopathology; Dyslipidemias - therapy; Exercise Therapy; Female; Health Status; Humans; Inflammation - blood; Inflammation - diagnosis; Inflammation - physiopathology; Inflammation - therapy; Inflammation Mediators - blood; Lipids - blood; Low-grade inflammation; Male; Middle Aged; Obesity - blood; Obesity - diagnosis; Obesity - physiopathology; Obesity - therapy; Original Investigation; Oxygen Consumption; Physical Fitness; Receptors, Urokinase Plasminogen Activator - blood; Secondary prevention; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha - blood; Weight Loss; Denmark; Secondary prevention; Low-grade inflammation; Dyslipidaemia; Aerobic interval training; Coronary artery disease; Weight loss
• ISSN: 1475-2840; 1475-2840
• DOI: 10.1186/s12933-019-0934-x

Dyslipidaemia and low-grade inflammation are central in atherogenesis and linked to overweight and physical inactivity. Lifestyle changes are important in secondary prevention of coronary artery disease (CAD). We compared the effects of combined weight loss and interval training with interval training alone on physical fitness, body composition, dyslipidaemia and low-grade inflammation in overweight, sedentary participants with CAD. Seventy CAD patients, BMI 28-40 kg/m and age 45-75 years were randomised to (1) 12 weeks' aerobic interval training (AIT) at 90% of peak heart rate three times/week followed by 40 weeks' AIT twice weekly or (2) a low energy diet (LED) (800-1000 kcal/day) for 8-10 weeks followed by 40 weeks' weight maintenance including AIT twice weekly and a high-protein/low-glycaemic load diet. Effects of the intervention were evaluated by physical fitness, body weight and composition. Dyslipidaemia was described using both biochemical analysis of lipid concentrations and lipoprotein particle subclass distribution determined by density profiling. Low-grade inflammation was determined by C-reactive protein, soluble urokinase-type plasminogen activator receptor and tumour necrosis factor α. Effects on continuous outcomes were tested by mixed-models analysis. Twenty-six (74%) AIT and 29 (83%) LED + AIT participants completed the study. At baseline subject included 43 (78%) men; subjects averages were: age 63 years (6.2), body weight 95.9 kg (12.2) and VO peak 20.7 mL O /kg/min (4.9). Forty-six (84%) had pre-diabetes (i.e. impaired fasting glucose and/or impaired glucose tolerance). LED + AIT reduced body weight by 7.2 kg (- 8.4; - 6.1) and waist circumference by 6.6 cm (- 7.7; - 5.5) compared to 1.7 kg (- 0.7; - 2.6) and 3.3 cm (- 5.1; - 1.5) after AIT (within-group p < 0.001, between-group p < 0.001 and p = 0.018, respectively). Treatments caused similar changes in VO peak and lowering of total cholesterol, triglycerides, non-HDL cholesterol and low-grade inflammation. A shift toward larger HDL particles was seen following LED + AIT while AIT elicited no change. Both interventions were feasible. Both groups obtained improvements in VO peak, serum-lipids and inflammation with superior weight loss and greater central fat loss following LED + AIT. Combined LED induced weight loss and exercise can be recommended to CAD patients. Trial registration NCT01724567, November 12, 2012, retrospectively registered (enrolment ended in April 2013).